News
Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out ...
Hosted on MSN2mon
Globus Medical strengthens SCS market position with $250m Nevro dealFollowing strong financial results revealed last month, US-headquartered Globus Medical has agreed ... It announced plans to lay off up to 5% of its workforce in January 2024 as part of a ...
Globus Medical, Inc. GMED recently completed its previously disclosed acquisition of Nevro Corp., a global medical device company that delivers comprehensive, life-changing solutions for the ...
Globus Medical (NYSE:GMED) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments ...
Globus Medical Inc. (NYSE:GMED) shares have reached an unprecedented peak, touching an all-time high of $93.68. With a market capitalization of $12.7 billion and an impressive revenue growth of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results